Acorah Software Products - Accounts Production 19.4.351 false true 31 March 2025 1 April 2024 false 1 April 2025 31 March 2026 31 March 2026 10741773 Mr Patrick Wallace Mr Benjamin Weatherall Mr Jody O'Neill false iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10741773 2025-03-31 10741773 2026-03-31 10741773 2025-04-01 2026-03-31 10741773 frs-core:CurrentFinancialInstruments 2026-03-31 10741773 frs-core:Non-currentFinancialInstruments 2026-03-31 10741773 frs-core:OtherReservesSubtotal 2025-03-31 10741773 frs-core:OtherReservesSubtotal 2026-03-31 10741773 frs-core:SharePremium 2025-03-31 10741773 frs-core:SharePremium 2026-03-31 10741773 frs-core:ShareCapital 2026-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses 2025-04-01 2026-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2025-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses 2026-03-31 10741773 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 10741773 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 10741773 frs-bus:SmallEntities 2025-04-01 2026-03-31 10741773 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 10741773 frs-bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 10741773 frs-bus:OrdinaryShareClass1 2025-04-01 2026-03-31 10741773 frs-bus:OrdinaryShareClass1 2026-03-31 10741773 1 2025-04-01 2026-03-31 10741773 frs-core:CostValuation 2025-03-31 10741773 frs-core:AdditionsToInvestments 2026-03-31 10741773 frs-core:DisposalsRepaymentsInvestments 2026-03-31 10741773 frs-core:CostValuation 2026-03-31 10741773 frs-core:ProvisionsForImpairmentInvestments 2025-03-31 10741773 frs-core:ProvisionsForImpairmentInvestments 2026-03-31 10741773 frs-bus:Director1 2025-04-01 2026-03-31 10741773 frs-bus:Director2 2025-04-01 2026-03-31 10741773 frs-bus:Director3 2025-04-01 2026-03-31 10741773 frs-countries:EnglandWales 2025-04-01 2026-03-31 10741773 2024-03-31 10741773 2025-03-31 10741773 2024-04-01 2025-03-31 10741773 frs-core:CurrentFinancialInstruments 2025-03-31 10741773 frs-core:Non-currentFinancialInstruments 2025-03-31 10741773 frs-core:OtherReservesSubtotal 2024-03-31 10741773 frs-core:OtherReservesSubtotal 2025-03-31 10741773 frs-core:SharePremium 2024-03-31 10741773 frs-core:SharePremium 2025-03-31 10741773 frs-core:ShareCapital 2024-03-31 10741773 frs-core:ShareCapital 2025-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2024-03-31 10741773 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 10741773 frs-bus:OrdinaryShareClass1 2024-04-01 2025-03-31
Registered number: 10741773
Ecare Group Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2026
Andrew Lillingston Limited
13 Hurlingham Studios
Ranelagh Gardens
London
SW6 3PA
Contents
Page
Balance Sheet 1—2
Statement of Changes in Equity 3
Notes to the Financial Statements 4—6
Page 1
Balance Sheet
Registered number: 10741773
2026 2025
Notes £ £ £ £
FIXED ASSETS
Investments 4 71,102 1,103
71,102 1,103
CURRENT ASSETS
Debtors 5 14,219,560 11,925,027
Cash at bank and in hand 45,200 114,154
14,264,760 12,039,181
Creditors: Amounts Falling Due Within One Year 6 (94,164 ) (89,742 )
NET CURRENT ASSETS (LIABILITIES) 14,170,596 11,949,439
TOTAL ASSETS LESS CURRENT LIABILITIES 14,241,698 11,950,542
Creditors: Amounts Falling Due After More Than One Year 7 (445,383 ) (68,554 )
NET ASSETS 13,796,315 11,881,988
CAPITAL AND RESERVES
Called up share capital 8 210 210
Share premium account 11,592,829 11,592,829
Other reserves 24,617 -
Profit and Loss Account 2,178,659 288,949
SHAREHOLDERS' FUNDS 13,796,315 11,881,988
Page 1
Page 2
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Benjamin Weatherall
Director
21/10/2026
The notes on pages 4 to 6 form part of these financial statements.
Page 2
Page 3
Statement of Changes in Equity
Share Capital Share Premium Other reserves Profit and Loss Account Total
£ £ £ £ £
As at 1 April 2024 191 10,400,860 - 367,722 10,768,773
Loss for the year and total comprehensive income - - - (78,773 ) (78,773)
Arising on shares issued during the period 19 1,191,969 - - 1,191,988
As at 31 March 2025 and 1 April 2025 210 11,592,829 - 288,949 11,881,988
Profit for the year and total comprehensive income - - - 1,889,710 1,889,710
Convertible loan note reserve - - 24,617 - 24,617
As at 31 March 2026 210 11,592,829 24,617 2,178,659 13,796,315
Page 3
Page 4
Notes to the Financial Statements
1. General Information
Ecare Group Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10741773 . The registered office is 18 Ashwin Street, London, England, E8 3DL.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Financial Instruments
Convertible Redeemable Loan Notes
Recognition and measurement
Convertible redeemable loan notes are classified on initial recognition into their liability and equity components where the terms of the instrument contain both a contractual obligation to deliver cash and an option allowing conversion into a fixed number of the Company's ordinary shares.
The liability component represents the present value of future interest and principal payments discounted at the market rate of interest applicable to a similar debt instrument without the conversion feature. The equity component is recognised as the residual amount after deducting the fair value of the liability component from the total proceeds received.
The liability component is subsequently measured at amortised cost using the effective interest method. Finance costs recognised in profit or loss comprise both the coupon interest payable and the amortisation of any discount arising on initial recognition.
The equity component is not subsequently remeasured.
Interest
Interest on the loan notes is recognised in profit or loss using the effective interest method and is presented within finance costs.
Conversion
Where loan notes are converted into ordinary shares in accordance with their contractual terms, the carrying amount of the liability component and the related equity component are transferred to share capital and share premium. No gain or loss is recognised on conversion.
Redemption
Upon redemption, the liability component is extinguished when the Company's obligation to repay the principal and any accrued interest is discharged. Any difference between the carrying amount of the liability and the consideration paid is recognised in profit or loss.
2.3. Exemption from preparing consolidated financial statements
The Company, and the Group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and Group are considered eligible for the exemption to prepare consolidated accounts.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2025: 3)
3 3
Page 4
Page 5
4. Investments
Subsidiaries
£
Cost or Valuation
As at 1 April 2025 1,103
Additions 70,001
Disposals (2 )
As at 31 March 2026 71,102
Provision
As at 1 April 2025 -
As at 31 March 2026 -
Net Book Value
As at 31 March 2026 71,102
As at 1 April 2025 1,103
5. Debtors
2026 2025
£ £
Due within one year
Amounts owed by group undertakings 14,219,485 11,924,952
Other debtors 75 75
14,219,560 11,925,027
6. Creditors: Amounts Falling Due Within One Year
2026 2025
£ £
Bank loans and overdrafts 18,554 55,660
Other loans 39,890 -
Other creditors 35,720 34,082
94,164 89,742
7. Creditors: Amounts Falling Due After More Than One Year
2026 2025
£ £
Bank loans - 18,554
Other loans 445,383 50,000
445,383 68,554
10.8% Unsecured convertible redeemable loan notes 2025
On 18 July 2025, the company issued 10.8% unsecured convertible redeemable loan notes to investors. The loan note facility was £500,000, of which £470,000 was subscribed and issued during the year.
The loan notes bear interest at a fixed rate of 10.8% per annum and are redeemable on 17 July 2027 unless previously converted into ordinary shares of the company at the option of the noteholders in accordance with the terms of the loan note instrument.
...CONTINUED
Page 5
Page 6
7. Creditors: Amounts Falling Due After More Than One Year - continued
The loan notes have been accounted for as a compound financial instrument. The liability component was initially recognised at the present value of the future contractual cash flows, discounted at the estimated market rate of interest for an equivalent non-convertible instrument of 13.98%. The residual amount has been recognised within equity as the convertible loan note reserve.
8. Share Capital
2026 2025
Allotted, called up and fully paid £ £
2,099,834 Ordinary Shares of £ 0.0001 each 210 210
9. Reserves
Share Premium Other reserves Profit and Loss Account
£ £ £
As at 1 April 2025 11,592,829 - 288,949
Profit for the year and total comprehensive income - - 1,889,710
Convertible loan note reserve - 24,617 -
As at 31 March 2026 11,592,829 24,617 2,178,659
10. Related Party Transactions
During the year, the company made advances totalling £2,294,533 to its subsidiary undertakings. At 31 March 2026, the balance due from the subsidiary undertakings was £14,219,485 (2025: £11,924,952).  
The loans are unsecured, interest-free, and repayable on demand.  
11. Controlling Party
No individual or entity holds a controlling interest in the company. 
Page 6